nubioage bpc-157 GUTTIDES™ nuBioAge Regenatides - Great Lakes

Q4: Are there any side effects associated with these treatments

BPC-157s ability to promote angiogenesis is vital here, potentially restoring blood flow to these starving nerves, while ARA-290 combats the systemic inflammation caused by the metabolic disease

The treatment plan is a loading phase of injections every other day for around two weeks, then maintenance every two to three months for life when the cause is not dietary, or twice a year when it is

Intranasal administration delivers the peptide efficiently to central nervous system targets, though peripheral effects on neurotrophic factor production may also benefit peripheral nerve health indirectly